Related by context. All words. (Click for frequent words.) 69 Factor VIIa 68 Civacir 68 faropenem 68 RECOTHROM ® 67 JAK inhibitor 67 PDE4 inhibitor 67 hyaluronidase enzyme 67 orally administered inhibitor 67 immunotherapeutic vaccine 67 vivo validation 67 TKM ApoB 67 ospemifene 66 novel therapeutic antibodies 66 MOVIPREP R 66 glucokinase activator 66 selective modulator 66 acyclovir Lauriad R 66 therapeutic monoclonal antibody 66 volociximab 66 Insegia 66 PREOS R 66 Protexia ® 66 CMV vaccine 66 RNAi therapeutic targeting PCSK9 66 Allovectin 7 R 66 Spiegelmer ® 66 MORAb 66 Evoltra ® 66 CytoFabTM 65 Potelligent Technology 65 methylnaltrexone bromide 65 rhMBL 65 DPX Survivac 65 oral prodrug 65 intranasal formulation 65 THR beta agonist 65 Granulocyte Colony Stimulating Factor 65 humanized monoclonal 65 hypoxia activated prodrug 65 beta 1a 65 AEG# 65 FOLOTYN ® 65 Surfaxin LS 65 YONDELIS 65 bardoxolone 65 Kosan dependence 65 Campath ® 65 JAK2 inhibitor 65 NPC 1C 65 StemEx 65 chimeric monoclonal antibody 65 ATL# [002] 65 ZFP Therapeutics 65 GVAX ® 65 optimal dosing regimens 65 diarrhea predominant irritable 65 Cx# [002] 65 antibody MAb 65 OvaRex R 65 CCR9 antagonist 65 molecular imaging radiopharmaceutical 65 Altastaph 65 Archexin 65 IMA# 65 MAXY VII 65 novel oral anticoagulant 65 nalbuphine ER 65 ONCONASE R 65 PHX# 64 XL# anticancer compounds 64 factor VIIa 64 Xanafide 64 cathepsin K inhibitor 64 forodesine 64 Clolar ® 64 GTC recombinant human 64 Aviptadil 64 HDL Selective Delipidation 64 ZFN modified 64 SUTENT ® 64 initiated Phase Ib 64 synthetic siRNA 64 mertansine 64 tubulin inhibitor 64 RECOTHROM R 64 Virulizin ® 64 HuMax TAC 64 Personalized Immunotherapy 64 interleukin IL -# 64 Squalamine 64 IMiDs R 64 plasmid DNA vaccine 64 Endotis 64 acetonide FA 64 Alferon N 64 Onalta 64 intranasal insulin product 64 CAMPATH 64 protein tyrosine phosphatase 1B 64 novel histone deacetylase 64 Argatroban 64 TBC# 64 vidofludimus 64 Onconase 64 Nanobody R 64 Panzem R 64 synthetic peptide containing 64 oncolytic virus therapies 64 pathophysiological effects 64 Intravenous Human 64 BrachySil TM 64 Recombinant Human 64 Cumulase 64 HQK 64 selective immunoproteasome inhibitor 64 CEQ# 64 Prodarsan R 64 RAV# 64 MKC# MKC# PP 64 cMET inhibitor 64 RhuDex ® 64 oral picoplatin 63 BCR ABL inhibitors 63 adecatumumab MT# 63 BioDelivery Sciences Announces 63 Aplidin 63 Initiates Enrollment 63 cMET 63 ORENCIA R 63 small molecule thrombopoietin 63 coagulation factor VIIa 63 Cancidas 63 Vitaxin 63 GTC recombinant form 63 Vidaza azacitidine 63 Prodarsan ® 63 RNAi therapeutic targeting 63 Myocet 63 antisense inhibitors 63 Solazed 63 non nucleoside 63 epigenetic therapies 63 Phenoptin 63 MAGE A3 ASCI 63 rxRNA 63 PEGylated 63 MVA BN 63 oral Hsp# inhibitor 63 Initiates Phase II 63 JAK inhibitors 63 Mipomersen 63 ATryn ® 63 soluble tumor necrosis 63 NeuroSTAT ® 63 HuMax CD4 63 Omacetaxine 63 depsipeptide 63 EP #R 63 huC# DM4 63 Collategene 63 R#/MEM # 63 Thelin tm 63 SYCREST 63 UPLYSO 63 ® bortezomib 63 Phase #b/#a clinical 63 rThrombin 63 HCV polymerase 63 humanised monoclonal antibody 63 anti CD3 monoclonal 63 Valtropin 63 receptor tyrosine kinase inhibitor 63 Lovaza TM 63 recombinant biopharmaceutical 63 elotuzumab 63 oral salmon calcitonin 63 EndoTAG TM 63 inhaled AAT 63 polymerase inhibitor 63 ularitide 63 EVIZON TM 63 Trofex 63 XP# XP# 63 A3 adenosine receptor 63 ADAMTS# 63 KSP inhibitor 63 NV1FGF 63 Inhalation Solution 63 developing TB4 63 Alvesco R 63 CRD5 63 ChimeriVax JE 63 Initiate Clinical Trial 63 unoprostone isopropyl 63 MT#/MEDI-# 63 HuLuc# 63 Reports Preclinical Data 63 ThermoDox R 63 Micromet BiTE 63 humanized anti 63 Initiates Clinical Trial 63 polyclonal antibody 63 BLA filing 63 NovaBay Aganocide compounds 63 recombinant FVIII 63 Preclinical studies suggest 63 humanized antibody 63 Capesaris 63 AzaSite Plus 63 Dual Opioid TM 63 XL# XL# 63 Elafin 63 biased ligand 63 Maribavir 63 Panzem R NCD 63 Curosurf 63 Onalta ™ 63 Cleviprex TM clevidipine 63 SuperAntibody 63 cannabinor 63 ALN TTR 63 factor TNF receptor 63 PNP inhibitor 63 KIACTA ™ 63 synthetic retinoid 62 Initiates Clinical 62 Fc fusion protein 62 Amrubicin 62 alvespimycin 62 R sorafenib tablets 62 Cetrorelix 62 IMiDs ® 62 anticoagulant reversing agent 62 uricase 62 HCD# [002] 62 Loramyc TM 62 ALN TTR# 62 chimeric antibody 62 CRMD# 62 Fabry Disease 62 BioNumerik 62 Bioral Amphotericin B 62 INTEGRILIN R eptifibatide Injection 62 Microplasmin 62 Ganciclovir 62 humanised antibody 62 HGS# 62 aurora kinase 62 Allovectin 7 62 Dapagliflozin 62 Urocidin TM 62 Urocidin 62 MyVax ® 62 lomitapide 62 incyclinide 62 Duromist ™ 62 proteasome inhibitor 62 Lixivaptan 62 Cethromycin 62 LEUKINE 62 Monoclonal antibody 62 sargramostim 62 Thrombin topical Recombinant 62 TRX1 62 MAb 62 outlicensed 62 GRNVAC1 62 recombinant plasma 62 Immunotherapeutic 62 Dalbavancin 62 topical ophthalmic 62 CG# [003] 62 novel peptide 62 demonstrated antitumor activity 62 Syntonix 62 isoform selective 62 SynCon 62 Tyzeka Sebivo 62 IL# PE#QQR 62 deforolimus 62 KL4 Surfactant 62 TNF Tumor Necrosis Factor 62 JOULFERON 62 Zorbtive TM 62 PEGylated interferon 62 StemEx R 62 GTC NASDAQ GTCB 62 MEK inhibitor 62 herpetic keratitis 62 PSN# [001] 62 BENLYSTA ® 62 PEGylated Fab fragment 62 PrevOnco ™ 62 Phase III Pivotal 62 Silodosin 62 Aryplase 62 intravenous AAT 62 Liprotamase 62 lumiliximab 62 Xcytrin R 62 adrenergic regulation 62 HuCNS SC ® 62 midkine 62 LHRH antagonist 62 ELACYT 62 valtorcitabine 62 pain palliation 62 human C1 inhibitor 62 Zavesca r 62 kidney urologic 62 Oral Insulin 62 OMAPRO ™ 62 ARIKACE ™ 62 AQ4N 62 candidate TNFerade biologic 62 PRTX 62 Plicera 62 LC#m# 62 Pruvel 62 pan HDAC inhibitor 62 Phase IIb clinical trials 62 immatics 62 Oasmia 62 AERx iDMS 62 immuno therapeutic 62 Onalta TM 62 thalidomide Thalomid 62 Vascular Wrap TM 62 micafungin 62 therapeutic monoclonal antibodies 62 Fibrillex TM 62 Leukine ® 62 Cloretazine ® 62 Tarvacin TM 62 Plasmin 62 Tezampanel 62 Begins Dosing 62 GATTEX TM 62 Fresenius Biotech 62 hyperphenylalaninemia HPA due 62 Firdapse 62 TNF alpha selectively neutralizing 62 sterile lidocaine patch 62 Degarelix 62 lucinactant 62 CTAP# Capsules 62 GVAX R 62 investigational humanized monoclonal antibody 62 Genz # 62 LUCASSIN 62 fluoroquinolone antibiotic 62 recombinant albumin 62 oral PTH 62 ALN RSV program 62 TransVax ™ 62 siRNA therapeutic 62 small molecule activators 62 refractory chronic lymphocytic 62 targeted antifolate 62 successfully commercialize Iluvien 62 2A receptor agonist 62 Hedgehog antagonist 62 C1INH 62 hypereosinophilic syndrome 62 romazarit 62 Gamunex C 62 K RAS 62 INCB# [001] 62 ATL# [001] 62 ulimorelin 62 histone deacetylase inhibitor 62 gastro intestinal inflammation 62 telomerase therapeutic 62 HyperAcute 62 Anthim 62 peripherally acting 62 Mycamine 62 receptor inhibitor 62 mGluR2 positive 62 Olmesartan 62 Japanese Encephalitis vaccine 61 Nippon Shinyaku 61 sunitinib malate 61 GLPG# 61 Solazed TM 61 RELOVAIR ™ 61 Prestara 61 Icatibant 61 epothilone 61 Maxy G# 61 IMiDs ® compound 61 AAG geldanamycin analog 61 Multiple Ascending Dose 61 vapreotide acetate 61 Desmoteplase 61 Somatuline Depot 61 Syncria R 61 Vidofludimus 61 AzaSite Xtra 61 Meets Primary Endpoint 61 XmAb# 61 adult mesenchymal stem 61 Aflibercept 61 Cellegesic 61 Cinryze ™ 61 pharmacokinetic PK study 61 Valortim TM 61 NTDDS 61 Tamibarotene 61 mitogen activated ERK kinase 61 JAK3 61 Neo Bladder Augment 61 Anticalins R 61 VitiGam TM 61 Triapine 61 Androxal ® 61 hyperimmune 61 ALN PCS 61 OncoGel 61 lipid nanoparticle 61 Novolimus 61 cetuximab Erbitux R 61 Relivar 61 ZALBIN 61 anticancer compound 61 CYT# potent vascular disrupting 61 Anidulafungin 61 CIMZIA ™ 61 CCX# 61 omega interferon 61 rFactor XIII 61 terlipressin 61 Saxagliptin 61 SNT MC# 61 reslizumab 61 antisense drug 61 YONDELIS R 61 ketolide antibiotic 61 Orally administered 61 Zemplar Capsules 61 Protexia R 61 Kuvan TM sapropterin 61 SILENOR 61 trastuzumab Herceptin R 61 Hsp# Inhibitor 61 Macrolide 61 siRNAs targeting 61 Zirgan 61 Aurexis 61 antisense inhibition 61 Interferon alpha 61 maribavir 61 ARRY # 61 Azedra TM 61 PDX pralatrexate 61 Phase 2a clinical trials 61 epoetin zeta 61 toenail onychomycosis 61 GW# [003] 61 Solasia 61 Ceflatonin 61 LibiGel ® 61 Presents Preclinical Data 61 Antitumor 61 Levoleucovorin 61 RIGScan CR 61 COLAZAL R 61 INS# [001] 61 KNS # 61 class mGluR5 inhibitor 61 Receives Orphan Drug 61 Syncria 61 LymphoStat B belimumab 61 Qutenza TM 61 Solulin 61 MGd 61 doxercalciferol 61 ATryn ® GTC recombinant 61 Completes Patient Enrollment 61 Sylvie Gregoire President 61 Phase Ib study 61 inhaled formulation 61 anti CD3 61 CYP#A# CYP#D# 61 Canvaxin TM 61 IgG1 antibody 61 Telatinib 61 CytoFab 61 ruxolitinib 61 oncolytic virus 61 Achieves Primary Endpoint 61 ddRNAi 61 Omacor ® 61 OncoVex 61 Pitavastatin 61 thetreatment 61 SPRYCEL ® 61 IV Busulfex 61 oral talactoferrin 61 Lactoferrin 61 FRDA 61 Romidepsin 61 Bendamustine 61 Familial Adenomatous Polyposis FAP 61 trastuzumab DM1 T DM1 61 Somatuline R Autogel R 61 Zenpep 61 NEUGENE R 61 Aloxi R 61 Zemiva TM 61 SUVN 61 avian transgenic 61 Successfully Completes Phase 61 tiapamil 61 Proellex TM 61 Loramyc R 61 peptide conjugated 61 Phase 1a clinical 61 Phase 2b Clinical Trial 61 Virulizin R 61 LBH# 61 selective kinase inhibitor 61 personalized immunotherapy 61 SinuNase ™ 61 Bezielle 61 Phospha E 61 multiple myeloma MM 61 LEX System 61 Shigamabs ® 61 tkRNAi 61 DXL TM 61 GLP toxicology studies 61 pDNA vaccine 61 octreotide implant 61 XP #L 61 TNFerade TM 61 SPL# Gel vaginal microbicide 61 Luteinizing Hormone Releasing Hormone 61 APTIMA HPV assay 61 Oral NKTR 61 mesylate 61 histamine dihydrochloride 61 GRN# 61 Aeolus Pharmaceuticals Announces 61 Vaxfectin 61 Nanobody 61 torezolid 61 epoetin alpha 61 JAK Inhibitor 61 CCR5 mAb 61 HuCAL GOLD R 61 Vaxfectin R 61 AMPYRA ® 61 BCR ABL inhibitor 61 Virulizin 61 Kahalalide F 61 Azedra 61 DCCR 61 Dacogen decitabine 61 Peginterferon alfa 2b 61 metaglidasen 61 Bazedoxifene 61 PNT# 61 Prolastin C 61 Varespladib 61 CD# antibody [001] 61 Alfacell proprietary ribonuclease 61 MyVax R 61 FOR FURTHER INFORMATION ABOUT 61 EndoTAG TM -1 61 Proquin XR 61 potently inhibits 61 alemtuzumab MS 61 AGS PSCA 61 intranasal formulations 61 Cloretazine 61 FDA APPROVES 61 ENMD # 61 DCVax R 61 anticancer therapeutics 61 Fludara ® 61 Fingolimod 61 novel VDA molecule 61 topical formulations 61 HuMax Inflam 61 registrational trial 61 Loramyc 61 Lenocta 61 VISICOL R 61 Gentamicin Surgical Implant 61 Trodusquemine 61 PLK1 SNALP 61 adenosine injection 61 pegylated recombinant 61 ATG Fresenius S 61 Initiates Phase III 61 MEK inhibitors 61 nicotinic alpha 7 61 PDE# inhibitors 61 Curaxin 61 Lispro 61 ChronVac C R 61 REGEN trial 61 liposomal formulation 61 blood clot dissolver 60 hyaluronidase rHuPH# 60 Homspera TM 60 inhibit metastasis 60 atacicept 60 CD# CEA 60 Martin Nicklasson CEO 60 rhLF 60 NXL# 60 A1PI 60 mTOR inhibition 60 TELINTRA 60 Nanobody ® 60 therapeutic peptide 60 TLK# 60 oxaliplatin Eloxatin 60 Certican 60 biologic therapeutics 60 Increlex R 60 RhuDex 60 castrate resistant prostate cancer 60 #D#C# 60 Traficet EN 60 RTP #i 60 VaxImmune 60 autoimmune indications 60 non nucleoside inhibitor 60 Olaparib 60 urate oxidase 60 generation purine nucleoside 60 Kineret R 60 DepoCyt 60 PEGPH# 60 Tofacitinib 60 torezolid phosphate 60 Th2 cytokines 60 LEVADEX ™ 60 INSPIRE Trial Phase III 60 JUVISTA R Human 60 Tasimelteon 60 recombinant Factor VIIa 60 GenWay Biotech 60 Selective Electrochemical Tumor Ablation 60 DeveloGen 60 Pancreate 60 PSN# [002] 60 CIMZIA TM 60 Pegloticase 60 Vascugel 60 miconazole MBT 60 Japanese Encephalitis Vaccine 60 compound AEOL # 60 SCIB1 60 delivers fluocinolone acetonide FA 60 human IgG1 monoclonal 60 Fibrin Pad 60 Poly ICLC 60 Dermylex TM 60 mda 7 60 HCV protease inhibitors 60 MTP inhibitor 60 DXL# 60 Pafuramidine 60 DOS# 60 Preotact R 60 CDP# 60 Quark Biotech 60 Pivotal Phase III 60 OMNARIS Nasal Spray 60 LEVADEX TM 60 Crofelemer budesonide foam 60 BioSante Pharmaceuticals Announces 60 dihydrochloride 60 delta opioid receptor 60 HuCAL antibodies 60 Captisol enabled 60 ATPace TM 60 Zalypsis 60 Submits IND 60 pitavastatin 60 monoclonal anti 60 HuCAL R 60 NOX E# 60 Ocrelizumab 60 clevidipine 60 tramiprosate Alzhemed TM 60 ELADUR TM 60 DPP4 inhibitor 60 Tesmilifene 60 Manja Bouman CEO 60 PTHrP 60 BRIM2 60 Angioblast 60 EVIZON ™ 60 AERx ® 60 catheter occlusion 60 HSP# inhibitors 60 cGMP manufacture 60 targeting CD# 60 pralatrexate injection folate analogue 60 butyrylcholinesterase 60 H#N# VLP vaccine 60 Thrombin 60 RhuDex TM 60 evaluating tivozanib 60 Multipotent 60 monoclonal antibody therapeutics 60 VitiGam 60 elbion 60 Teplizumab 60 tranilast 60 HepeX B 60 targeted radiotherapeutic 60 adenoviral 60 apaziquone 60 LAB CGRP 60 murine model 60 adenosine A2A 60 levocetirizine 60 Kineret ® 60 peptide receptor 60 recombinant factor VIIa 60 Exelixis compounds 60 Granted Orphan Drug 60 Dermylex ™ 60 Urokinase 60 Vaxfectin R adjuvant 60 Scancell 60 bendamustine HCl 60 HuMax EGFr 60 next generation URAT1 60 Ampligen ® 60 Pharmacokinetics PK 60 alpha#beta# integrin 60 vinorelbine tartrate 60 Minapharm 60 Trastuzumab DM1 60 Exherin TM 60 BRIM3 60 Wellstat 60 Sopherion 60 AZX# 60 phase IIb clinical 60 RhuDex R 60 receptor blocker 60 Parathyroid Hormone 60 Intravenous CP 60 REPLAGAL 60 Phase 1b trial 60 AFREZZA TM 60 Soliris eculizumab 60 PF # [002] 60 Phase Ib II 60 inhibits VEGF 60 molecular chaperone regulation 60 TLR9 agonist 60 HuMax 60 HCl Tablets 60 REGiMMUNE 60 Vernakalant 60 Receives Orphan Drug Designation 60 preclinical efficacy 60 TRANSDUR Bupivacaine 60 inhaled liposomal ciprofloxacin 60 AVP #D# 60 Ecallantide 60 reduce serum phosphate 60 PEGylated anti 60 fosbretabulin 60 phase IIb trial 60 Parkinson disease levodopa induced 60 systemic RNAi 60 Poly ICR 60 vaccine GRNVAC1 60 interferon gamma 1b 60 Firazyr 60 RH1 60 mediated inhibition 60 FS Antihemophilic Factor Recombinant 60 STEDESA 60 INOmax R 60 P#X# antagonist 60 effector function 60 UltiMAb 60 Ascend Therapeutics 60 candidates Azedra TM 60 OncoVEX 60 Bicifadine 60 neratinib 60 Ventavis ® 60 Troxatyl 60 vascular disrupting agents 60 potently inhibited 60 Tracleer R 60 tolevamer 60 induced macular edema 60 Chinese Hamster Ovary 60 oral proteasome inhibitor 60 budesonide foam 60 ceftazidime 60 R Saizen R 60 PYY #-# 60 Capsulution 60 anti botulism antibody 60 Nexavar sorafenib 60 Velcade bortezomib 60 confirmatory clinical 60 HepaGam B 60 Tarmogen 60 sJIA 60 injectable collagenase 60 Daclizumab 60 BIM #A# 60 ACV1 60 Initiate Phase 60 oral ghrelin agonist 60 Elagolix 60 wilate ® 60 Vidaza R 60 BEMA Granisetron 60 Viprovex TM 60 Initiates Phase 2b 60 Temsirolimus 60 Safinamide 60 ONCASPAR 60 laninamivir 60 Lubiprostone 60 GAMMAGARD 60 essential thrombocythemia ET 60 polycythemia vera essential thrombocythemia 60 Thalomid ® 60 ESTRASORB 60 OXIGON TM 60 hoFH 60 Aptivus ® 60 Panzem 60 Tracleer r 60 PGL# 60 sodium glucose transporter 60 polyclonal antibodies 60 Transdermal Patch 60 Darinaparsin 60 ZEVALIN ® 60 multicenter Phase II 60 Phase IIIb clinical 60 DDP# 60 Cimzia TM 60 apricitabine ATC 60 denileukin diftitox 60 Presents Preclinical 60 ProMune 60 cartilage regeneration 60 luliconazole 60 GCase 60 acadesine 60 RezularTM 60 metastatic neuroendocrine tumors 60 orally bioavailable 60 Multimeric 60 PEG SN# 60 Ruconest 60 LHRH receptor positive 60 HepDirect prodrug 60 TRACON Pharmaceuticals 60 #I TM# 60 Aurora kinase inhibitor 60 delafloxacin 60 Gleevec resistant 60 pediatric acute lymphoblastic 60 paclitaxel poliglumex 60 ONTAK 60 Peptidomics 60 PRN FDA Approves 60 SUMAVEL 60 nucleoside analog 60 CCR1 60 HepeX B TM 60 Oncaspar 60 CCX# B 60 VivaGel ™ 60 MSCRAMM R 60 BEXXAR 60 alefacept 59 NS5b 59 Locteron ® 59 Alnylam #x# 59 Interferon Beta 59 HCV protease inhibitor 59 GHRH 59 GRNCM1 59 stable nucleic acid 59 thrombolytic agent 59 Actimmune ® 59 mild vasodilator 59 ESBA# 59 SinuNase TM 59 vinca alkaloid 59 iobenguane 59 lipopeptide 59 Chrysalin 59 torsemide ER 59 HDL Mimetic Peptide 59 novel antibody therapeutics 59 phase IIa clinical 59 ocular formulation 59 Ketotransdel 59 DiLA2 59 oral methylnaltrexone 59 PORxin TM platforms 59 novel orally bioavailable 59 systemic RNAi therapeutic 59 haematological cancers 59 MYDICAR 59 EyeGate 59 Crofelemer 59 candidate REP# 59 Factor IX 59 By JENNIFER LEARN 59 rusalatide acetate 59 Febuxostat 59 Epigenomics proprietary 59 otelixizumab 59 Fortical R 59 initiate Phase 2b 59 trivalent influenza vaccine 59 OHR/AVR# 59 Cathepsin S 59 NEBIDO R 59 balsalazide tablet 59 Certolizumab pegol 59 Anticalin ® 59 tremelimumab 59 HSP# inhibitor 59 patented Bioral 59 OMP #R# 59 pentostatin 59 Marqibo TM 59 PD LID 59 Panzem NCD 59 highly purified pasteurized 59 Zemiva ™ 59 Diamyd R 59 platform HDL Mimetic 59 Neulasta R 59 dSLIM 59 Circ Pharma 59 ghrelin antagonist 59 cinacalcet 59 selective androgen receptor modulator 59 MyoCell SDF 1 59 MKC# MT 59 IIa trials 59 Myolimus 59 EnzymeRx 59 eprotirome 59 PSMA ADC 59 DiaPep# 59 IgG1 59 lintuzumab SGN 59 IgG1 antibodies 59 EDEMA3 59 lixivaptan 59 RESOLOR 59 CA9 SCAN 59 epothilones 59 selective agonist 59 Myeloperoxidase 59 Azacitidine 59 Sym# 59 Dasatinib 59 JAK1 59 cytotoxic T lymphocyte 59 Adnectin 59 Sebivo 59 EGS# 59 Rotarix ® 59 porcine derived 59 entinostat 59 ZFP Therapeutic TM 59 Quinamed 59 CCR9 59 ThermoDox ® clinical 59 hMG 59 cancer immunotherapies 59 Vaxfectin R formulated 59 Zavesca R 59 relapsed MM 59 Numax 59 Alzhemed TM 59 DURIN TM 59 ALTROPANE 59 PROSTVAC VF 59 Indomethacin 59 initiate Phase IIa 59 BrachySil ™